Myomo (MYO) EPS (Weighted Average and Diluted) (2021 - 2025)
Myomo (MYO) has disclosed EPS (Weighted Average and Diluted) for 5 consecutive years, with -$0.08 as the latest value for Q3 2025.
- For the quarter ending Q3 2025, EPS (Weighted Average and Diluted) fell 166.67% year-over-year to -$0.08, compared with a TTM value of -$0.28 through Sep 2025, down 21.74%, and an annual FY2024 reading of -$0.16, up 42.86% over the prior year.
- EPS (Weighted Average and Diluted) was -$0.08 for Q3 2025 at Myomo, up from -$0.12 in the prior quarter.
- Across five years, EPS (Weighted Average and Diluted) topped out at -$0.01 in Q4 2024 and bottomed at -$0.5 in Q4 2021.
- Average EPS (Weighted Average and Diluted) over 5 years is -$0.2, with a median of -$0.11 recorded in 2023.
- The sharpest move saw EPS (Weighted Average and Diluted) soared 92.86% in 2023, then tumbled 300.0% in 2025.
- Year by year, EPS (Weighted Average and Diluted) stood at -$0.5 in 2021, then surged by 44.0% to -$0.28 in 2022, then surged by 75.0% to -$0.07 in 2023, then surged by 90.16% to -$0.01 in 2024, then tumbled by 1061.45% to -$0.08 in 2025.
- Business Quant data shows EPS (Weighted Average and Diluted) for MYO at -$0.08 in Q3 2025, -$0.12 in Q2 2025, and -$0.08 in Q1 2025.